Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Tipo de estudio
País de afiliación
Intervalo de año de publicación
1.
Mem Inst Oswaldo Cruz ; 108(4): 508-11, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23828001

RESUMEN

Trypanosoma cruzi infects humans when infected triatomine vector excreta contaminate breaks in skin or mucosal surfaces. T. cruzi insect-derived metacyclic trypomastigotes (IMT) invade through gastric mucosa after oral challenges without any visible inflammatory changes, while cutaneous and conjunctival infections result in obvious local physical signs. In this study we compared the infectivity of T. cruzi IMT in mice after cutaneous and oral contaminative challenges simulating natural infections. The 50% infective dose (ID50) for oral challenge was 100 fold lower than the ID50 for cutaneous challenge, indicating that oral mucosal transmission is more efficient than cutaneous transmission.


Asunto(s)
Enfermedad de Chagas/transmisión , Insectos Vectores/parasitología , Trypanosoma cruzi/patogenicidad , Animales , Enfermedad de Chagas/parasitología , Ratones , Ratones Endogámicos BALB C , Proteínas Protozoarias/fisiología
2.
Front Immunol ; 11: 442, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32318055

RESUMEN

Computational vaccinology includes epitope mapping, antigen selection, and immunogen design using computational tools. Tools that facilitate the in silico prediction of immune response to biothreats, emerging infectious diseases, and cancers can accelerate the design of novel and next generation vaccines and their delivery to the clinic. Over the past 20 years, vaccinologists, bioinformatics experts, and advanced programmers based in Providence, Rhode Island, USA have advanced the development of an integrated toolkit for vaccine design called iVAX, that is secure and user-accessible by internet. This integrated set of immunoinformatic tools comprises algorithms for scoring and triaging candidate antigens, selecting immunogenic and conserved T cell epitopes, re-engineering or eliminating regulatory T cell epitopes, and re-designing antigens to induce immunogenicity and protection against disease for humans and livestock. Commercial and academic applications of iVAX have included identifying immunogenic T cell epitopes in the development of a T-cell based human multi-epitope Q fever vaccine, designing novel influenza vaccines, identifying cross-conserved T cell epitopes for a malaria vaccine, and analyzing immune responses in clinical vaccine studies. Animal vaccine applications to date have included viral infections of pigs such as swine influenza A, PCV2, and African Swine Fever. "Rapid-Fire" applications for biodefense have included a demonstration project for Lassa Fever and Q fever. As recent infectious disease outbreaks underscore the significance of vaccine-driven preparedness, the integrated set of tools available on the iVAX toolkit stand ready to help vaccine developers deliver genome-derived, epitope-driven vaccines.


Asunto(s)
Epítopos de Linfocito T/genética , Medicina de Precisión/métodos , Linfocitos T Reguladores/inmunología , Vacunas/inmunología , Virosis/inmunología , Animales , Bioingeniería , Bioterrorismo , Modelos Animales de Enfermedad , Humanos , Vacunación Masiva , Informática Médica , Vacunas/genética
3.
Mem. Inst. Oswaldo Cruz ; 108(4): 508-511, jun. 2013. tab
Artículo en Inglés | LILACS | ID: lil-678288

RESUMEN

Trypanosoma cruzi infects humans when infected triatomine vector excreta contaminate breaks in skin or mucosal surfaces. T. cruzi insect-derived metacyclic trypomastigotes (IMT) invade through gastric mucosa after oral challenges without any visible inflammatory changes, while cutaneous and conjunctival infections result in obvious local physical signs. In this study we compared the infectivity of T. cruzi IMT in mice after cutaneous and oral contaminative challenges simulating natural infections. The 50% infective dose (ID50) for oral challenge was 100 fold lower than the ID50for cutaneous challenge, indicating that oral mucosal transmission is more efficient than cutaneous transmission.


Asunto(s)
Animales , Ratones , Enfermedad de Chagas/transmisión , Insectos Vectores/parasitología , Trypanosoma cruzi/patogenicidad , Enfermedad de Chagas/parasitología , Ratones Endogámicos BALB C , Proteínas Protozoarias/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA